Diane Harper
Diane Harper is a prominent medical professional and researcher known for her extensive work in the field of human papillomavirus (HPV) and cervical cancer. She has made significant contributions to the development and study of HPV vaccines, including Gardasil and Cervarix.
Early Life and Education[edit]
Diane Harper was born and raised in the United States. She pursued her undergraduate studies in biology and chemistry before moving on to medical school. She completed her medical degree and later specialized in obstetrics and gynecology (OB/GYN), with a particular focus on oncology.
Career[edit]
Harper has held numerous academic and clinical positions throughout her career. She has served as a professor at the University of Missouri and the University of Louisville, where she conducted extensive research on HPV and cervical cancer.
Harper's research has primarily focused on the prevention of cervical cancer through HPV vaccination. She played a crucial role in the clinical development and study of the HPV vaccines Gardasil and Cervarix. Her work has significantly contributed to our understanding of the efficacy and safety of these vaccines.
Controversy[edit]
Despite her contributions to the development of HPV vaccines, Harper has been a vocal critic of the way these vaccines have been marketed and used. She has expressed concerns about the long-term efficacy of the vaccines and the potential for adverse side effects. These views have sparked controversy and debate within the medical community.
Publications[edit]
Harper has published numerous articles in peer-reviewed medical journals. Her work has been widely cited and has significantly influenced the field of HPV research and cervical cancer prevention.
Awards and Recognition[edit]
Over the course of her career, Harper has received numerous awards and recognition for her contributions to the field of medicine and research.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
